Refluxassociated changes of the remant esophagus after esophagectomy and gastric interposition– Gastrointestinal Function Testing during long time follow up in patients with esophageal cancer

Phase 3

• Conditions: K21.0; Gastro-oesophageal reflux disease with oesophagitis

• Registration Number: DRKS00011123
• Lead Sponsor: Klinik und Poliklinik für Allgemein-, Viszeral- und TumorchirurgieUniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-30
• Study Completion: 2018-11-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

Patients with esophagus carcinoma that underwent hybrid Ivor Lewis esophagectomy and that gave their written consent

Exclusion Criteria

None

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients will undergo 24-h laryngopharyngeal pH measurement (Restech)and intraluminal impedance pH-monitoring at the same time so that the relationship between the two techniques can be evaluated (for assessment of gastrointestinal function).

Secondary Outcome Measures

Name	Time	Method
Also they will undergo a routine check-up program with a surveillance endoscopie. <br>To evaluate the symptoms patients are asked to fill out a standardized questionnaire (GERD HRQL). When we collected all the data we can evaluate the relationship between the two different techniques and the symptoms of the patient.